Deregulation of the Rb and p53 pathways in uveal melanoma

被引:85
|
作者
Brantley, MA
Harbour, JW
机构
[1] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA
[2] Washington Univ, Div Mol Oncol, St Louis, MO 63110 USA
来源
AMERICAN JOURNAL OF PATHOLOGY | 2000年 / 157卷 / 06期
关键词
D O I
10.1016/S0002-9440(10)64817-1
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Uveal melanoma is the most common primary eye cancer, yet its molecular pathogenesis is poorly understood. In this study, we investigated the immunohistochemical expression of proteins in the Rb and p53 tumor suppressor pathways in 33 uveal melanomas from enucleated eyes. Strong nuclear staining for Rb was present in most tumors. However, a few cases displayed weak nuclear staining and strong cytoplasmic staining (possibly indicating Rb mutation), and this aberrant staining correlated strongly with failed radiotherapy or thermotherapy before enucleation. Staining for cyclin D1 was positive in most tumors and was associated with advanced age and larger tumor size, which are both poor prognostic factors. Generally, immunostaining for p53 was weak (suggesting a lack of p53 mutations), although p53 positivity correlated strongly with staining for phosphorylated Rb, supporting the notion that inappropriate phosphorylation of Rb can induce p53, Strong immunostaining for MDM2, which can functionally block p53 activity, was observed in most tumors and correlated significantly with female sex. Strong cytoplasmic staining was observed for Bc12, which can inhibit both p53-dependent and -independent apoptosis, We conclude that Rb and p53 are mutated infrequently in uveal melanoma, but their respective pathways may be functionally inactivated.
引用
收藏
页码:1795 / 1801
页数:7
相关论文
共 50 条
  • [1] The Rb and p53 tumor suppressor pathways in uveal melanoma and retinoblastoma.
    Harbour, JW
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S308 - S308
  • [2] P53 AND UVEAL MELANOMA
    COHEN, J
    GHAZVINI, S
    KISHORE, K
    KROLL, S
    CHAR, DH
    OBRIEN, JM
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S393 - S393
  • [3] The RB and p53 pathways in cancer
    Sherr, CJ
    McCormick, F
    CANCER CELL, 2002, 2 (02) : 103 - 112
  • [4] Deregulation of the Rb/E2F and the p53 pathways in Peyronie's disease
    Mulhall, JP
    Martin, D
    Lubrano, T
    Shankey, TV
    Choubey, D
    JOURNAL OF UROLOGY, 2002, 167 (04): : 204 - 204
  • [5] p53 gene and cell cycling in uveal melanoma
    Kishore, K
    Ghazvini, S
    Char, DH
    Kroll, S
    Selle, J
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1996, 121 (05) : 561 - 567
  • [6] Expression of P53 protein in primary uveal melanoma
    Sulkowski, S
    Sulkowska, M
    Famulski, W
    Chyczewski, L
    Bakunowicz-Lazarczyk, A
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2001, 39 (02): : 159 - 160
  • [7] P53 STAINING CORRELATES WITH CELL CYCLING IN UVEAL MELANOMA
    KISHORE, K
    GHAZVINI, S
    CHAR, DH
    SELLE, J
    KROLL, S
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S494 - S494
  • [8] Mutational analysis of selected genes in the TGFβ, Wnt, pRb, and p53 pathways in primary uveal melanoma
    Edmunds, SC
    Kelsell, DP
    Hungerford, JL
    Cree, IA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 (09) : 2845 - 2851
  • [9] p53/Rb
    Minna, John
    Augustyn, Alexander
    Earnest, Svetlana
    Dospoy, Patrick
    Johnson, Jane
    Cobb, Melanie
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S137 - S137
  • [10] Altered expression of Rb and p53 in uveal melanomas following plaque radiotherapy
    Brantley, MA
    Worley, L
    Harbour, JW
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2002, 133 (02) : 242 - 248